Patent · US Expired

4-Hydroxytetrahydropyran-2-one derivatives

US5149834A · kind A · utility

3Cited by
2References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 7, 1991
Grant dateSep 22, 1992
Priority date
Expiry dateMar 7, 2011

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D407/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

4-hydroxytetrahydropyran-2-one derivatives with general formula (I) are useful as cholesterol reducing agents as well as lipid reducing agents, serving as inhibitors of HMG-CoA reductase, and capable of inhibiting the biosynthesis of peroxidized lipids, and therefore effective for curing arteriosclerosis: ##STR1## wherein R.sub.1 represent hydrogen or a 2-tetrahydropyranyl group; R.sub.2 and R.sub.3 each represent hydrogen or an alkyl group having 1 to 6 carbon atoms; R.sub.4 represents hydrogen, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an aryl group, an aralkyl group, an acyl group, an aroyl group or a substituted sulfonyl group; A represents --CH.sub.2 CH.sub.2 --, or --CH.dbd.CH--; and n is an integer of 1 or 2, and intermediates for synthesizing the 4-hydroxytetrahydropyran-2-one derivatives are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.